Abstract Caveolin-3 (Cav-3) plays a critical role in organizing signaling molecules and ion channels involved in cardiac conduction and metabolism. Mutations in Cav-3 are implicated in cardiac conduction abnormalities and myopathies. Additionally, cardiac-specific overexpression of Cav-3 (Cav-3 OE) is protective against ischemic and hypertensive injury, suggesting a potential role for Cav-3 in basal cardiac electrophysiology and metabolism involved in stress adaptation. We hypothesized that overexpression of Cav-3 may alter baseline cardiac conduction and metabolism. We examined: (1) ECG telemetry recordings at baseline and during pharmacological interventions, (2) ion channels involved in cardiac conduction with immunoblotting and computational modeling, and (3) baseline metabolism in Cav-3 OE and transgene-negative littermate control mice. Cav-3 OE mice had decreased heart rates, prolonged PR intervals, and shortened QTc intervals with no difference in activity compared to control mice. Dobutamine or propranolol did not cause significant changes between experimental groups in maximal (dobutamine) or minimal (propranolol) heart rate. Cav-3 OE mice had an overall lower chronotropic response to atropine. The expression of K v 1.4 and K v 4.3 channels, Na v 1.5 channels, and connexin 43 were increased in Cav-3 OE mice. A computational model integrating the immunoblotting results indicated shortened action potential duration in Cav-3 OE mice linking the change in channel expression to the observed electrophysiology phenotype. Metabolic profiling showed no gross differences in VO 2 , VCO 2 , respiratory exchange ratio, heat generation, and feeding or drinking. In conclusion, Cav-3 OE mice have changes in ECG intervals, heart rates, and cardiac ion channel expression. These findings give novel mechanistic insights into previously reported Cav-3 dependent cardioprotection.
Introduction
Caveolae are small ''flask-like'' invaginations of the sarcolemmal membrane discovered over six decades ago [37, 62] . Recent work has identified caveolae as signaling epicenters made up of essential scaffolding proteins called caveolins. Caveolae and caveolins are necessary for the precise temporal and spatial localization and organization of cellular signaling molecules [22, 38] involved in cardiac protection [21, 46, [55] [56] [57] and cardiac remodeling [20] . There are three distinct caveolin (Cav) isoforms including Cav-1 and Cav-2, which are ubiquitous in all cell types, and Cav-3 which is found predominantly in skeletal and cardiac myocytes [11, 41, 52] . Cav-3, via its scaffolding domain, has been shown to interact with numerous signaling molecules including G-protein-coupled receptors (GPCRs), ion channels, and receptor tyrosine kinases [22, 38, 53] . Mice with cardiac-specific overexpression of caveolin-3 (Cav-3 OE) demonstrate tolerance to myocardial ischemia and left ventricular pressure overload suggesting stress adaptation of the heart [20, 55] .
Cav-3 plays an integral role in organizing signaling molecules that are essential for the generation of heart rate, rhythm, and cardiac chronotropy [10, 29, 58, 65] . Cav-3 mutations have been implicated in cardiac arrhythmias, particularly prolonged QT syndrome, given their association with adrenergic receptors and ion channels. Furthermore, specific chronotropic ion channels have been localized within caveolae including SCN5A-encoded voltage-gated Na ? channels [64] , voltage-dependent K ?
channel [2] , sodium calcium exchangers [7, 8] , and L-Type Ca 2? channels [3, 28] . Despite these provocative findings regarding Cav-3 expression and cardiac conduction, there are no data regarding the effect of Cav-3 overexpression in the heart on basic electrophysiology and metabolism. In the current study, we describe baseline cardiac conduction and metabolism in Cav-3 OE mice as a means to add mechanistic insight into the alterations in stress adaption previously observed in Cav-3 OE mice.
Materials and methods

Animals
All mice were treated in compliance with the Guide for the Care and Use of Laboratory Animals (National Academy of Science) and the protocols were approved by the VA San Diego Healthcare System Institutional Animal Care and Use Committee. Animals were kept on a 12-h lightdark cycle (with light on from 6:00 to 18:00 hours) in a temperature-controlled room with ad libitum access to food and water. Transgenic mice were generated in our laboratory using the a-myosin heavy chain promoter to produce cardiac myocyte-specific overexpression of Cav-3 (Cav-3 OE) in a C57BL/6 background. Full-length Cav-3 cDNA (455 bp) was cloned into a vector containing the a-myosin heavy chain promoter and was used for microinjection by the UCSD Transgenic Core. Cav-3 OE mice have a *1.8-fold increase in caveolin-3 protein in whole heart homogenates [55] . Transgene-negative littermates were used as control mice. All experiments were performed on male mice. Telemetry 4-to 5-month-old male Cav-3 OE (N = 7/group) and control mice (N = 8/group) were anesthetized with 1.4 % isoflurane. A small peritoneal incision was made and the transmitter [ETA-F10, Data Sciences International (DSI), Inc, St. Paul, MN, USA] was inserted into the peritoneal cavity. The leads were secured in the right thorax and lower abdominal regions according to the manufacturer's protocol. Continuous signals were transmitted wirelessly to the receivers located below the cage. Animals were given analgesia (buprenorphine) and allowed to recover for 72 h. Mice were then acclimated for 10 days without analgesia. All mice were housed in ventilated cages with ad libitum food and water. Light and dark cycles were maintained using automatic timers. Continuous telemetry recordings were monitored for 72 h using Dataquest ART software (Data Sciences International, Inc., St. Paul, MN, USA) and analyzed with the programs default mouse parameters. QTc was measured using previously published derived equations for conscious mice, QTc = QT/SQRT(RR/100) [32, 67] .
Pharmacological studies
Heart rate response to b-adrenergic stimulation (dobutamine, 4 mg/kg), parasympathetic blockade (atropine, 1 mg/kg), b-adrenergic blockade (propranolol, 1 mg/kg), and autonomic blockade (atropine and propranolol) were obtained. Intra-peritoneal dobutamine was injected and heart rate was averaged over 60 s intervals and monitored for 60 min. Mice were then allowed to rest 6 h before being given intra-peritoneal atropine and then the heart rate was monitored for 120 min with 5-min intervals. The following day, intra-peritoneal propranolol was injected and the heart rate recorded for 5 h with 15-min intervals. After 6 h, a second injection of propranolol and atropine was given and the heart rate was recorded for an additional 120 min with 5-min intervals.
Immunoblotting
Immunoblotting was performed on adult mouse ventricular homogenates prepared from either control or Cav-3 OE mice (N = 5-7/group). Homogenates were solubilized using ice-cold 11 mmol/L Tris-HCl, pH 7.4, 1.1 mmol/L EDTA, 0.2 % SDS, 11 % glycerol, and protease inhibitors (2 mM phenylmethylsulfonyl fluoride, 12 lg/ml aprotinin, 1 mM benzamidine, 10 lM leupeptin, 5 lM pepstatin A). The lysate was centrifuged at 5000g for 10 min to remove insoluble debris. The protein content was estimated in the soluble supernatant and an equal amount of each sample was analyzed by SDS/PAGE (4-15 % gradient gels, BioRad) and Western blot by probing with antibodies to Cav-3, connexin 43 (Cx43) and GAPDH (Millipore), K v 1.4, K v 4.2, and K v 4.3 antibodies (NeuroMab, UC Davis, CA), Ca v 1.2 antibody (Alomone labs, Jerusalem, Israel), and Na v 1.5 antibody (Millipore Corporation). Protein signals for Cav-3 and channel subunits were quantified by normalizing the signal to GAPDH.
Computational modeling
A recently published murine ventricular action potential model [33] was used to investigate the observed changes in ion channel expression in the Cav-3 OE mice. This computational model consists of a system of 158 ordinary differential equations describing the myocyte ion channels and Ca 2? handling as well as PKA and CaMKII signaling networks. The model source code was obtained from the author's website (https://somapp.ucdmc.ucdavis.edu/Phar macology/bers/) [33] , and all simulations were executed using the ode15s algorithm in MATLAB (The MathWorks, Inc., Natick, MA, USA). In the absence of functional ion channel data, previous studies have meaningfully incorporated differences in ion channel transcript levels into an action potential model by scaling the whole-cell ion channel conductance based on relative differences [6, 9] . Similarly, we created a Cav-3 OE version of the action potential model by scaling the ion channel conductance by statistically significant changes in ion channel protein expression measured by Western blot. The action potential duration (APD) was measured with respect to the control repolarization levels, so that changes in action potential amplitude alone would not alter the APD results.
CLAMS metabolic cage
Metabolic studies were performed at the UCSD Phenotyping Core facility. In brief, animals were placed in temperatureand light-controlled CLAMS metabolic cages (Columbus Instruments, Columbus, OH, USA) and oxygen uptake, carbon dioxide output, respiratory exchange ratio (RER), feeding, and drinking were recorded continuously for 2.5 days.
Statistics
Investigators were blinded to the genetic background of mice in all study protocols. Statistical analysis was performed with GraphPad Prism Software v6.0 (La Jolla, CA, USA). All values are presented as mean ± standard deviation [M (SD)]. Two-way or two-way repeated measure (RM) ANOVA followed by post hoc Tukey's correction for multiple comparisons and unpaired Student's t test were utilized. An a-level of p \ 0.05 for all statistical tests was used.
Results
Cav-3 OE and control mice showed similar activity and body temperature during telemetry recording Cav-3 OE and control mice (N = 7-8/group) were investigated during telemetry recording and the total activity (arbitrary units) was measured. Cav-3 OE mice showed similar activity to control mice over a two-and-a-half-day period (Fig. 1a) . In detail, we found a main effect of time [F (9, 117) = 29.57, p \ 0.001], with both strains displaying less activity during the light cycle (6:00-18:00 hours) and no main effect of strain [F (1, Cav-3 OE mice have lower 24-h heart rates and show higher heart rate fluctuation
Continuous ECG recording in conscious mice (DSI) showed physiological heart rates in control and Cav-3 OE mice; however, heart rates from Cav-3 OE mice changed significantly over time compared to control mice. The heart rate of control mice ranged from 513 to 555 beats per minute (bpm), whereas that of Cav-3 OE mice ranged from 468 to 580 bpm during minimal and maximal amounts of activity ( Fig. 1c ) with significantly lower resting heart rates. In detail, we found a main effect of time [F (9, 117) = 10.73, p \ 0.001], with both strains displaying a lower heart rate during the light cycle (6:00-18:00 hours).
No main effect of strain [F (1, 13) = 2.23, p = 0.16] was observed. We furthermore found a significant interaction between time and strain [F (9, 117) = 2.98, p = 0.003], with Cav-3 OE mice showing a higher fluctuation of heart rate with overall lower heart rates recorded. However, the difference between strains was observed more clearly when the heart rates were averaged over a 24-h time frame ( Cav-3 OE mice have altered heart rate responses to cardiac pharmacological agents when compared to control mice Conscious Cav-3 OE and control mice (N = 8/group) were injected with various inotropic and chronotropic agents and the heart rate was recorded (DSI). Analysis was performed for the time period after the injection. Both, Cav-3 OE and control mice exhibited increased chronotropy (*200 bpm) with injection of dobutamine, a known sympathomimetic drug used to stimulate b 1 adrenergic receptors (Fig. 3a) . Interestingly, Cav-3 OE mice recovered nearly 10 min sooner than control mice at baseline heart rate. We found a main effect of time [F (41, 533) = 23.66, p \ 0.001] with both strains displaying altered heart rates over time. The main effect of strain [F (1, 13) = 4.44, p = 0.06] and interaction between time and strain [F (41, 533) = 0.71, p = 0.913] was not significant. Atropine, a competitive antagonist of the muscarinic acetylcholine receptors, increased heart rate similarly in Cav-3 OE and control mice. However, Cav-3 OE mice had overall lower heart rates in response to atropine compared to control mice Propranolol, a non-selective beta-blocker (Fig. 3c) caused a maximal reduction in heart rate at *75 min in both groups, but Cav-3 OE mice had sustained lower heart rates for nearly two additional hours, whereas heart rate in control mice recovered much sooner. We found a main When both propranolol and atropine were injected, lower heart rates were noted in both groups (Fig. 3d) . However, no significant difference between groups was observed. For these data, we found a main A computation model of ventricular myocytes from Cav-3 OE mice predicted shortened action potential duration
To better understand the effects of altered ion channel expression on the observed electrophysiology phenotype, significant changes in protein expression from Fig. 4 were incorporated into a computation model of a mouse ventricular myocyte action potential. The conductance of the fast component of the transient outward potassium current (G to,f ), carried by the K v 4.3 channel protein, was increased 2.2-fold from 0.44 to 0.97 mS/lF, and the conductance of the fast sodium channel (G Na ), carried by the Na v 1.5 channel protein, was increased 1.7-fold from 10 to 17 mS/lF. The slow component of the transient outward potassium current (I to,s ), carried by the K v 1.4 channel protein, was not included in the original model [33] as its expression was typically limited to septal myocytes in the mouse [61] . The resulting Cav-3 action potential model has shortened action potential duration (APD) compared to the control model (Fig. 5a ). The maximum decrease in APD occurred at 50 % repolarization (APD 50 ; 55 % reduction at 6-Hz pacing) with a substantial decrease still present at 90 % repolarization (APD 90 ; 12 % at 6-Hz pacing) (Fig. 5b) . This change in APD is consistent across a range of heart rates (Fig. 5c) . Since the largest suppression in APD occurred in the voltage range important for calcium influx, intracellular calcium transients (CaT) were also evaluated in the model. There was a slight reduction in CaT amplitude at 1-Hz pacing (15 %) that decreased near physiological rates (9 % at 6-Hz pacing) (Fig. 5d) . The relative contributions of each conductance change were dissected by implementing them independently. The increased G to,f was wholly responsible for the decrease in action potential duration (Fig. 5e) . Increasing G to,f and G Na individually had opposing effects on CaT amplitude, resulting in the minimal resultant change in the Cav-3 OE model (Fig. 5f ).
Cav-3 OE mice have similar metabolic profiles
In addition to the telemetry studies, we also assessed metabolic parameters using CLAMS metabolic cages. Cav-3 OE and control mice were assessed for two-and-a-half days in CLAMS metabolic cages (N = 8/group). Furthermore, while time had a significant effect on all parameters with lower values during the light cycle, we found no statistically significant differences between strains in the weight before and after, weight change, VO 2 (ml/kg/h), VCO 2 (ml/kg/h), respiratory exchange ratio (RER), heat (kcal/h) generation, accumulated feeding (grams), and accumulated drinking (ml). Details and statistical analysis can be found in Table 1 .
Discussion
Cav-3 has been implicated in playing a role in cardiac rhythm, chronotropy [5, 10, 29, 58, 65] , and stress adaptation [20, 55] ; however, the effects of cardiac overexpression of Cav-3 on baseline cardiac conduction and metabolism have never been investigated. We have shown for the first time that cardiac-specific overexpression of Cav-3 results in significant lower heart rates at rest, prolonged PR interval, shortened QTc intervals, and alterations in ion channel expression, while baseline whole organism metabolism remains unchanged. The normal healthy heart relies on efficient electrical conduction via the sinoatrial node, the atrioventricular (inset) from simulated 6-Hz pacing for control (black line) and Cav-3 OE (gray line) model parameters. b APD was decreased in the Cav-3 OE model compared to control. c This decrease was consistent across a range of pacing rates. d Intracellular calcium transient amplitude was slightly decreased in the Cav-3 OE model with the effect diminishing near physiological rates. e The increase in G to,f was responsible for the decrease in APD. f Increasing G to,f and G Na had opposing effects on the CaT amplitude when applied individually node, and the Purkinje fibers to optimize cardiac contraction [14] . The rate at which the heart contracts is modified by various intrinsic and extrinsic signaling mechanisms [12] . Intrinsically, various ion channels regulate depolarization and repolarization of each individual myocyte. Interestingly, caveolins and caveolae have been associated with many of these ion channels as well as many G proteins that are known to interact with ion channels [4] . Mutations in Cav-3 can lead to congenital long-QT syndrome by affecting sodium ion channel regulation [58] . Furthermore, recent studies show that Cav-3 and caveolae are essential for stretch-dependent conduction slowing [40] . Finally, Cav-3 can form macromolecular complexes with one of the major subunits within the cardiac pacemaker channels, affecting cardiac conduction [5, 65] . These previous findings and our novel data suggest a critical role for Cav-3 in regulating cardiac conduction and chronotropy. We show that K v 1.4 and K v 4.3 channel protein expression levels are significantly increased in Cav-3 OE mice. K v channels via effects on I to currents are essential to cardiac repolarization. Indeed, when the channel protein expression differences measured in Cav-3 OE mice were used to scale whole-cell ion channel conductances in a mouse ventricular myocyte mode, the APD was shortened. APD 90 and QTc are closely related [67] , and the reduction in APD 90 from the model (12 % at 6-Hz pacing) was similar to the reduction in QTc measured with telemetry (13 %). These results suggest that the increase in K v channel expression is sufficient to explain the QTc decrease in Cav-3 OE mice. Although a severely shortened QT interval has been associated with congenital heart disorders that may cause cardiomyopathy and arrhythmias [44] , our mice do not exhibit any characteristics of cardiomyopathy even at old age (unpublished data) and have no increase in mortality when compared to littermate control mice. In contrast, Cav-3 OE mice have been shown to be resistant to myocardial ischemia and demonstrate increased survival in response to chronic pressure overload hypertrophy [20, 55] , with decreased hypertrophic response, suggesting a phenotype of stress adaptation. Many different signaling pathways are involved in cardioprotection [19] , and Cav-3 may serve as a molecular integrator of these various pathways.
Sinus bradycardia and prolonged PR interval are well documented in the trained athlete and are thought to be secondary to unknown intrinsic factors and modified by increased vagal tone on the sinoatrial pacemaker [27, 31] . Our data suggest that caveolins may be an intrinsic factor involved in the cardiac response to exercise via their multiple interactions with ion channels and other cell signaling molecules. Previous investigations have shown that Cav-3 mRNA is upregulated in trained animal hearts by approximately twofold [18] . Interestingly, our Cav-3 OE mice have an approximate twofold elevation of Cav-3 protein at baseline [55] . Short-and long-QT syndromes are both uncommon in trained athletes [43] . However, changes within the QT interval are observed during exercise and recovery and are known as QT hysteresis [42] . This shortening in the QT interval is exaggerated in long-QT syndrome and hysteresis has been suggested as a possible marker of long QT [25] . Interestingly, beta-blockade can normalize this exaggerated response as well as lower cardiac risk seen with long-QT syndrome [26, 34] . Furthermore, early repolarization and not terminal repolarization appears to be the major contributor to these changes [23] . The outward potassium current, I to , activates transiently in the sub-threshold range of membrane potential to initiate rapid repolarization following the action potential and helps to set the plateau membrane potential and subsequently the length of the QT interval and action potential duration [35] . In the heart, I to is formed from the heteromeric assembly of three primary alpha subunits (K v 1.4, K v 4.2, and K v 4.3), which are differentially expressed and associated with K v channel-interacting proteins (KChIPs) or the b subunits. The K v 4.2 and K v 4.3 a subunits contribute to the rapidly recovering (I to,f ) components, whereas K v 1.4 a subunits contributes to the slowly recovering (I to,s ) components in the ventricular myocytes [36, 39] . The K v 4.2 and K v 4.3 channels are shown to partition into caveolae by interacting with the A-kinase anchoring protein, AKAP100, and Cav-3 to form a macromolecular signaling complex [1] . These findings correlate with our results where K v 1.4 and K v 4.3 channels are overexpressed resulting in faster cardiac repolarization and possibly minimizing exaggerated QT hysteresis.
Cav-3 has also been implicated in voltage-gated sodium channel function. Cav-3 has been shown to co-immunoprecipitate with Na v 1.5 [58, 60, 64] (the a-subunit responsible for the inward sodium current resulting in phase 0 of the action potential). Disruption of this channel has been implicated in long-QT syndrome type 3 [48, 59, 60] and Brugada syndrome [45, 49, 50] . Most recently, in vitro, co-expression of mutant Cav-3 and Na v 1.5 resulted in prolonged action potential duration leading to a long-QT type 9-like phenotype [13] . Our results further support the relationship between Cav-3 and Na v 1.5, as Na v 1.5 is significantly increased in Cav-3 OE mice. However, the effect of increased Na v 1.5 expression on the phenotype is uncertain. The action potential model did not support a role for Na v 1.5 in the observed QTc decrease. This is consistent with the lack of APD or QTc changes in cardiacspecific SCN5A-overexpressing mice [66] . The increased Na v 1.5 expression may provide a compensatory effect to offset the I to -mediated decrease in CaT amplitude predicted by the computational model.
Previous studies have suggested a key role for Cx43 in electrical coupling and action potential propagation [17, 24] . We show that Cx43, a vital component in gap junction formation, is increased in Cav-3 OE hearts. An interaction between caveolins and Cx43 has been described [63] . A specific role for Cav-3 in S-nitrosylation of Cx43 in cardiac mitochondria has been suggested [15, 51, 54] . Others have shown that reduction of Cx43 and Na v 1.5 results in polymorphic ventricular arrhythmias in cardiac hypertrophy [16] . Interestingly, Cav-3 overexpression has been shown to protect against cardiac hypertrophic remodeling [20, 30] .
Extrinsically, cardiac conduction is modified via parasympathetic and sympathetic innervation [12] . Standard pharmacological agents were used to investigate the effects of potential extrinsic factors on cardiac conduction in Cav-3 OE mice, since caveolae and Cav-3 contain and interact, respectively, with many of these signaling molecules including GPCRs, G proteins, and adenylyl cyclases [38] . Interestingly, recovery from sympathetic stimulation with dobutamine was faster in Cav-3 OE mice and recovery from sympathetic blockade with propranolol was slower in Cav-3OE mice. Parasympathetic blockade with atropine produced a significantly decreased heart rate with a faster recovery in Cav-3 OE mice. Caveolins have been implicated in endocytosis [47] and perhaps Cav-3 OE promotes more efficient clearing of bound receptors that is altered in the presence of an antagonist. In addition, the chronotropic responses to adrenergic agonists were equivocal. These data suggest that Cav-3 overexpression likely does not alter extrinsic mechanisms involved in cardiac conduction, but may improve the efficiency and recovery of the cell membrane potential.
The current manuscript has potential limitations. Our data extrapolate ion channel expression to physiological changes and potential computational models. Patch clamp experiments to confirm these data are currently being performed by the laboratory. Similarly, data regarding Cav-3 KO animals that would support our conclusion are currently being performed as well. In addition, the pharmacological experiments were performed with IP injections rather than IV. It is possible that IV administration could result in altered pharmacological responses compared to those we report in this manuscript.
In conclusion, our data suggest that cardiac-specific overexpression of Cav-3 results in alterations in baseline cardiac conduction, heart rate, and expression levels of certain cardiac ion channels. Although further investigations are necessary to elucidate the full physiological and clinical implications of Cav-3 overexpression on heart rate control, our novel data support a critical role for Cav-3 in cardiac conduction. The changes observed in baseline cardiac conduction and ion channel expression in our study may provide further mechanistic insight into the phenotype of ischemic tolerance and resistance to pressure overloadinduced stress that have been observed previously in Cav3-OE mice.
